Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix

Obstetrics and Gynecology

Volumn 98, Issue 5, 2001, Pages 726-731

  McHale, Michael T ^a   Le, Thuan D ^a   Burger, Robert A ^a   Gu, Mai ^b   Rutgers, Joanne L ^b   Monk, Bradley J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CHILDBIRTH; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; FEMALE FERTILITY; FOLLOW UP; HUMAN; INVASIVE CARCINOMA; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; PAPANICOLAOU TEST; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION;

ADENOCARCINOMA; ADULT; CARCINOMA IN SITU; CERVIX UTERI; CONIZATION; FEMALE; FERTILITY; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; PREGNANCY; PREGNANCY OUTCOME; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 0034761230     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/00006250-200111000-00004     Document Type: Article

References (25)

1. Hepler TK, Dockerty MB, Randall LM. Primary adenocarcinoma of the cervix. Am J Obstet Gynecol 1952;63:800-8.
2. Betsill WL, Clark AH. Early endocervical glandular neoplasia I. Histomorphology and cytomorphology. Acta Cytol 1986;30:115-26.
3. Christopherson WM, Nealon N, Gray LA. Noninvasive precursor lesions of adenocarcinoma and mixed adenosquamous carcinoma of the cervix uteri. Cancer 1979;44:975-83.
4. Wolf JK, Levenbeck C, Malpica A, Morris M, Burke T. Mitchell MF. Adenocarcinoma in situ of the cervix: Significance of cone biopsy margins. Obstet Gynecol 1996;88:82-6.
5. Hopkins MP, Roberts JA, Schmidt RW. Cervical adenocarcinoma in situ. Obstet Gynecol 1988;71:842-4.
6. Im DD, Duska LR, Rosenshein NB. Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease. Gynecol Oncol 1995;59:179-82.
7. Widrich T, Kennedy AW, Myers TM, Hart WR, Wirth S. Adenocarcinoma in situ of the uterine cervix: Management and outcome. Gynecol Oncol 1996;61:304-8.
8. Schorge JO, Lee KR, Flynn CE, Goodman AK, Sheets EE. Stage IA1 cervical adenocarcinoma: Definition and treatment. Obstet Gynecol 1999;93:219-22.
9. Schorge JO, Lee KR, Sheets EE. Prospective management of Stage IA1 cervical adenocarcinoma by conization alone to preserve fertility; a preliminary report. Gynecol Oncol 2000;78:217-20.
10. Morris M, Mitchell MF, Silva EG, Copeland LJ, Gershenson D. Cervical conization as definitive therapy for early invasive squamous carcinoma of the cervix. Gynecol Oncol 1993;51:193-6.
11. Mestwerdt G. Die fruhdiagnose des kollumkarzinoms. Zentralbl Gynakol 1947;69:198-202.
12. Pecorelli S, Benedet JL, Creasman WT, Shepherd JH. FIGO staging of gynecologic cancer. Int J Gynaecol Obstet 1999;64:5-10.
13. Östör A, Duncan A, Quinn M, Rome R. Adenocarcinoma in situ of the uterine cervix: An experience with 100 cases. Gynecol Oncol 2000;79:207-10.
14. Poynor EA, Barakat RR, Hoskins WJ. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix. Gynecol Oncol 1995;57:158-64.
15. Kennedy AW, El Tabbakh GH, Biscotti CV, Wirth S. Invasive adenocarcinoma of the cervix following LLETZ for adenocarcinoma in situ. Gynecol Oncol 1995;58:274-7.
16. Azodi M, Chambers SK, Rutherford TJ, Kohorn EI, Schwartz PE, Chambers JT. Adenocarcinoma in situ of the cervix: Management and outcome. Gynecol Oncol 1999; 73:348-53.
17. Brown JV, Peters WA, Corwin DJ. Invasive carcinoma after cone biopsy for cervical intraepithelial neoplasia. Gynecol Oncol 1991;40:25-8.
18. Hocking GR, Hayman JA, Ostor AG. Adenocarcinoma in situ of the uterine cervix progressing to invasive adenocarcinoma. Aust N Z J Obstet Gynaecol 1996;36:218-20.
19. Smith HO, Tiffany MF, Quall CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States—a 24 year population based study. Gynecol Oncol 2000;78:97-105.
20. Östör A, Rome R, Quinn M. Microinvasive adenocarcinoma of the cervix: A clinicopathologic study of 77 women. Obstet Gynecol 1997;89:88-93.
21. Kaku T, Kamura T, Sakai K, Amada S, Kobayashi H, Shigematsu T, Nakano H. Early adenocarcinoma of the uterine cervix. Gynecol Oncol 1997;65:281-85.
22. Nicklin JL, Perrin LC, Crandon AJ, Ward BG. Microinvasive adenocarcinoma of the cervix. Aust N Z J Obstet Gynecol 1999;39:411-3.
23. Östör AG. Early invasive adenocarcinoma of the uterine cervix. Int J Gynecol Pathol 1999;19:29-38.
24. 1 adenocarcinoma of the cervix. Gynecol Oncol 2000;77:467-70.
25. Covens A, Kirby J, Shaw P, Chapman W, Franseen E. Prognostic factors for relapse and pelvic lymph node metastases in early stage I adenocarcinoma of the cervix. Gynecol Oncol 1999;74:423-7.